Transplantation in the Pandemic Era: Perspectives on the Utilization of COVID-19 Positive Organs
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.05.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Shreya Bhasin und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester School of Medicine and Dentistry, Rochester, New York. Hauptthemen laut MEDLINE: COVID-19, Tissue and Organ Procurement, Organ Transplantation, Tissue Donors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: At early stages of the pandemic, most organ procurements organizations considered COVID-19 infected donors to be ineligible for organ donation. The aim of this survey is to describe the current practices of the utilization of COVID-19 positive organs donors among American Society of Transplant Surgeons (ASTS) members. METHODS: An anonymous 40-question redcap survey was emailed to ASTS members from June to August 2022. RESULTS: One hundred forty-nine surveys from 10 countries were included for analysis. The majority of the responders were men (66.7%) from North America (95%) and identified as transplant surgeons (68.5%). Most work at academic institutions (76.5%). Almost all responders (94%) were willing to accept an organ from a donor with a history of COVID-19 who tested negative at the time of donation, however, there was no consensus on the length of time after the disease was resolved. Approximately 70% indicated they accept organs from asymptomatic donors with active disease. Only 32 responders indicated they would accept an organ from an individual with a history of "severe" COVID-19 infection and less than one third of the responders would accept an organ from a donor who died from COVID-19 infection. Interestingly, 80% indicated they have protocols at their institution to guide the acceptance of such organs. DISCUSSION: Despite new evidence that the transmission of COVID-19 in non-lung organs is extremely rare, the results of this survey suggest significant heterogeneity in practice and perceptions of the use of COVID-19 positive organs across international centers. We suggest that the implementation of a standardized protocol is of paramount importance to continue safe transplant activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Rochester School of Medicine and Dentistry, Rochester, New York.
- Department of Surgery, University of Rochester Medical Center, Rochester, New York.
- Department of Infectious Disease, University of Rochester Medical Center, Rochester, New York.
- Department of Transplant Surgery, University of Rochester Medical Center, Rochester, New York.
- Department of Transplant Surgery, University of Rochester Medical Center, Rochester, New York. Electronic address: karen_pineda-solis@urmc.rochester.edu.
Zitieren
APA
Bhasin, S., Byrne, M., Alpizar-Rivas, R., Chavez-Villa, M., Ruffolo, L., Cisneros, R., Prasad, P., & Pineda-Solis, K. (2024). Transplantation in the Pandemic Era: Perspectives on the Utilization of COVID-19 Positive Organs. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.037
Vancouver
Bhasin S, Byrne M, Alpizar-Rivas R, Chavez-Villa M, Ruffolo L, Cisneros R, et al. Transplantation in the Pandemic Era: Perspectives on the Utilization of COVID-19 Positive Organs. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.037
BibTeX
@article{Bhasin2024,
author = {Bhasin, Shreya and Byrne, Matthew and Alpizar-Rivas, Rodolfo and Chavez-Villa, Mariana and Ruffolo, Luis and Cisneros, Rafael and Prasad, Paritosh and Pineda-Solis, Karen},
title = {Transplantation in the Pandemic Era: Perspectives on the Utilization of COVID-19 Positive Organs},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.05.037}
}
EUVIMED